Type 2 Diabetes Mellitus
Conditions
Interventions
66 women will participate in the study, 33 from the Control Group (CG), who will be monitored in relation to glycemic control and nutritional guidelines
and 33 patients in the Experimental Group, who, in addition to glycemic monitoring and nutritional guidelines, will participate in a systematic and supervised resistance training protocol, lasting 40
Assessment of the level of physical activity using the short version of the International Physical Activity Questionnaire - IPAQ. Serum dosage to measure glucose levels, glycosylated hemoglobin, trigl
Measurement of lean body mass through dual X-ray densitometry exams (DEXA)
Application of the short physical performance test (Short Physical Performance Battery - SPPB) to assess balance, gait, strength and endurance
Evaluation of the muscular strength of the upper limbs using the Hand Grip Digital dynamometer
Evaluation of the participants' quality of life using the SF-36 quality of life questionnaire
and comparison of data from participants in the experimental group with those in the control group. The resistance training protocol will have the following steps: Warm up - 5 minutes of exercise with
Flexibility - 5 minutes for stretching the muscles of the lower, upper limbs and trunk
Resistance Training - 30 minutes of exercise with halters for large muscle g
Other
G11.427.410.698.277
Sponsors
Faculdade de Ciências Médicas de Pernambuco
PPGCS/UPE - Programa de Pós-Graduação em Ciências da Saúde
Eligibility
Sex/Gender
Female
Age
50 Years to 100 Years
Inclusion criteria
Inclusion criteria: Female patients, in the postmenopausal period, diagnosed with type 2 diabetes mellitus, with variations in the levels of glycosylated hemoglobin and are classified as being sedentary or irregularly active according to the International Physical Activity Questionnaire (IPAQ).
Exclusion criteria
Exclusion criteria: Past coronary or cerebrovascular event; carriers of chronic kidney disease with an estimated glomerular filtration rate less than or equal to 30 ml / min; orthopedic limitation for physical exercise; proliferative diabetic retinopathy; disabling diabetic neuropathy; NYHA class III or IV heart failure; established liver disease (Child B or C); decompensated thyroid disease; malignant neoplasm, except for basal cell carcinoma; in coronary, carotid or peripheral arterial revascularization schedule; documented myocardial ischemia; classified as active or very active by the International Physical Activity Questionnaire (IPAQ); participation in any training program using weights in the last 6 months; and with adherence to the systematic resistance training protocol below 80%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1 - Increase in muscle strength, verified by means of handgrip dynamometry, from the observation of a variation of at least 1kg/force in the pre and post intervention measurements.;Expected outcome 2 - Improvement of metabolic indicators: fasting glucose, glycosylated hemoglobin (HbA1c), triglycerides, cholesterol (HDL, LDL and total cholesterol), verified by means of serum dosage (blood test), from the finding of variation in pre and post intervention measures in relation to the reference values for each of the evaluated indicators.;Expected outcome 3 - Improvement in quality of life, verified through the SF-36 quality of life questionnaire, based on the observation of a variation of at least 5% in the values obtained by the questionnaire domain in the pre and post intervention measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected | — |
Countries
Brazil
Contacts
Public ContactThyago Santos
PPGCS/UPE - Programa de Pós-Graduação em Ciências da Saúde
Outcome results
None listed